III 

118TH CONGRESS 

2D SESSION S. RES. 726 

Designating June 6, 2024, as National Naloxone Awareness Day. 

IN THE SENATE OF THE UNITED STATES 

JUNE 5, 2024 

Mr. SCOTT of Florida (for himself, Mr. MARKEY, Mrs. CAPITO, Ms. CANTWELL, Mr. BRAUN, Mr. RUBIO, Mr. KING, Mr. MANCHIN, Mr. HEINRICH, 

Mr. WYDEN, Mr. LUJA ́N, Mr. BROWN, Mr. VAN HOLLEN, and Ms. 

ROSEN) submitted the following resolution; which was considered and 

agreed to 

RESOLUTION 

Designating June 6, 2024, as National Naloxone Awareness 

Day. 

Whereas the opioid epidemic continues to devastate communities across the United States, leading to a significant 

loss of life and widespread societal impact; 

Whereas opioid overdoses during the 12 months preceding 

December of 2023 claimed a reported 81,083 lives in the 

United States; 

Whereas fatal overdoses are often witnessed by a bystander; 

Whereas, in 2023 alone, the Drug Enforcement Administration seized more than 381,000,000 doses of potentially 

deadly fentanyl, enough to kill every individual in the 

United States; 


ssavage on LAPJG3WLY3PROD with BILLS
2 

•SRES 726 ATS 

Whereas, according to data from the Centers for Disease 

Control and Prevention, fentanyl-related poisonings are 

currently a leading cause of death for individuals in the 

United States between 18 and 45 years of age; 

Whereas naloxone is a safe and effective medication that can 

reverse opioid overdoses and save lives when administered 

promptly by rapidly reversing the effects of opioids; 

Whereas naloxone plays a vital role in preventing long-term 

brain damage and reducing the risk of fatality associated 

with opioid overdoses; 

Whereas the Centers for Disease Control and Prevention has 

declared naloxone to be a key tool in preventing opioid 

overdose deaths; 

Whereas it is imperative to educate individuals, families, 

healthcare professionals, and first responders about— 

(1) the benefits of naloxone, including the potential 

naloxone has to reduce opioid-related fatalities; and 

(2) how to safely administer naloxone; 

Whereas it is imperative to identify current or potential barriers, including cost, for individuals, organizations, and 

Federal, State, and local governments to obtain and distribute naloxone; 

Whereas increasing access to naloxone can ensure that individuals struggling with opioid use disorder have a chance 

at recovery and a future free from the grip of opioid use 

disorder; 

Whereas the Food and Drug Administration acted to authorize the over-the-counter sale of 4 milligram and 3 milligram doses of naloxone in 2023; and 

Whereas recognizing National Naloxone Awareness Day will 

contribute to the ongoing efforts to educate the public, 


ssavage on LAPJG3WLY3PROD with BILLS
3 

•SRES 726 ATS 

reduce stigma associated with substance use disorder, 

and promote access to lifesaving naloxone: Now, therefore, be it 

1 Resolved, That the Senate— 

2 (1) designates June 6, 2024, as National 

3 Naloxone Awareness Day; 

4 (2) recognizes the life-saving benefits of 

5 naloxone in reversing opioid overdoses and pre6 venting unnecessary deaths; 

7 (3) acknowledges that increased access to 

8 naloxone empowers individuals, families, healthcare 

9 professionals, and first responders to intervene in 

10 emergency situations and provide immediate assist11 ance to those experiencing an opioid overdose; 

12 (4) recognizes that National Naloxone Aware13 ness Day serves as an opportunity to educate the 

14 public about the importance of recognizing the signs 

15 of opioid overdose and equipping themselves with 

16 naloxone to save lives; 

17 (5) encourages Federal, State, and local govern18 ments, as well as private and nonprofit organiza19 tions, to collaborate and allocate resources towards 

20 increasing naloxone access, education, and distribu21 tion efforts; and 

22 (6) calls upon Federal agencies, including the 

23 Substances Abuse and Mental Health Services AdVerDate Sep 11 2014 01:38 Jun 06, 2024 Jkt 049200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\SR726.ATS SR726

ssavage on LAPJG3WLY3PROD with BILLS
4 

•SRES 726 ATS 

1 ministration, the Centers for Disease Control and 

2 Prevention, the Office of National Drug Control Pol3 icy, the Drug Enforcement Administration, and all 

4 others engaged in the National Drug Control Strat5 egy to continue supporting public awareness of 

6 naloxone, harm reduction, and overdose and poi7 soning prevention. 

Æ 


ssavage on LAPJG3WLY3PROD with BILLS